Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.68 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.68 |
| ▸ | RAB9A | P51151 | 1/20 | 0.68 |
| ▸ | HTT | P42858 | 1/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | GAA | P10253 | 2/20 | 0.65 |
| ▸ | DBH | P09172 | 1/20 | 0.65 |
| ▸ | RECQL | P46063 | 1/20 | 0.65 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.55 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28052189 | 0.88 | MEN1 (0.66) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| SCHEMBL15004192 | 0.86 | MEN1 (0.64) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| SCHEMBL25139441 | 0.86 | RECQL (0.65) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| SCHEMBL758674 | 0.85 | TSHR (0.66) | KDM4EGAADBHRECQLCYP1A2 | |
| SCHEMBL29472911 | 0.83 | MEN1 (0.60) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| SCHEMBL11539489 | 0.83 | MEN1 (0.64) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| SCHEMBL19769118 | 0.82 | TAS1R3 (0.52) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| SCHEMBL27968763 | 0.81 | MEN1 (0.72) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| SCHEMBL17106307 | 0.81 | KDM4E (0.59) | MEN1KMT2ASLC22A6SLC22A8RAB9A | |
| Apocynin SCHEMBL27893253 | 0.81 | HTT (0.65) | MEN1KMT2ASLC22A6SLC22A8RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| WO-2013173332-A1 | METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN | Vertichem Corporation (CA) | 2013-11-21 | — | — | WO | claimed |
| US-20130232852-A1 | METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN | THESIS CHEMISTRY, LLC (US) | 2013-09-12 | — | — | US | claimed |
| US-20130232853-A1 | METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN | THESIS CHEMISTRY, LLC (US) | 2013-09-12 | — | — | US | claimed |
| WO-2013134756-A1 | A METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN | Vertichem Corporation (CA) | 2013-09-12 | — | — | WO | claimed |
| US-6753441-B1 | CONDENSING, IN WATER AND BASE, HYDROXYLATED AROMATIC COMPOUND WITH GLYOXYLIC ACID USING POLYCARBOXYLIC ACID CATALYST | RHODIA CHIMIE (FR) | 2004-06-22 | — | — | US | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | disclosed |
| US-20230183159-A1 | METHOD FOR THE TREATMENT OF A COMPOSITION COMPRISING NATURAL VANILLIN | SPECIALTY OPERATIONS FRANCE (FR) | 2023-06-15 | — | — | US | disclosed |
| US-20230183159-A1 | METHOD FOR THE TREATMENT OF A COMPOSITION COMPRISING NATURAL VANILLIN | SPECIALTY OPERATIONS FRANCE (FR) | 2023-06-15 | — | — | US | disclosed |
| US-20230121337-A1 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CEDILLA THERAPEUTICS, INC. | 2023-04-20 | — | — | US | disclosed |
| US-20170283352-A1 | METHOD FOR PRODUCING AN AROMA SUBSTANCE | BASF SE (DE) | 2017-10-05 | — | — | US | disclosed |
| CN-101774897-B | Method for preparing vanillin and analogue thereof | UNIV EAST CHINA SCIENCE & TECH | 2014-03-19 | — | — | CN | disclosed |
| WO-2013173332-A1 | METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN | Vertichem Corporation (CA) | 2013-11-21 | — | — | WO | disclosed |
| US-5705703-A | ENZYME INHIBITORS OF TRANSFERASES | HOFFMANN-LA ROCHE INC. (US) | 1998-01-06 | — | — | US | disclosed |
| US-5633371-A | ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE | HOFFMANN-LA ROCHE INC. (US) | 1997-05-27 | — | — | US | disclosed |
| US-5476875-A | Catechol derivatives | HOFFMAN-LA ROCHE INC. (US) | 1995-12-19 | — | — | US | disclosed |
| US-5389653-A | Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease | HOFFMAN-LA ROCHE INC. (US) | 1995-02-14 | — | — | US | disclosed |
| US-5236952-A | Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa | HOFFMANN-LA ROCHE INC. (US) | 1993-08-17 | — | — | US | disclosed |
| EP-0237929-B1 | 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1993-06-02 | — | — | EP | disclosed |
| EP-0237929-A1 | 3,5-Disubstituted pyrocatechol derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1987-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230121337-A1 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CDK2, CDK20, CDK2AP2 | MEN1 3029/4885KMT2A 1017/4885SLC22A6 4466/4885 |
| US-20130232852-A1 | METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN | DCXR, AGL, GLO1 | MEN1 4418/4885KMT2A 2781/4885SLC22A6 4361/4885 |
| US-20130232853-A1 | METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN | HAAO, HAO2, HACL2 | MEN1 4741/4885KMT2A 2677/4885SLC22A6 4438/4885 |
| US-20230183159-A1 | METHOD FOR THE TREATMENT OF A COMPOSITION COMPRISING NATURAL VANILLIN | SDHA, COMT, NDUFV2 | MEN1 3426/4885KMT2A 3129/4885SLC22A6 3384/4885 |
| US-20170283352-A1 | METHOD FOR PRODUCING AN AROMA SUBSTANCE | ADH1A, H1-0, HRH3 | MEN1 772/4885KMT2A 408/4885SLC22A6 2919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.